Annals of Neurology Annals of Neurology, Wiley, 2021, 89 (4), pp.686-697. ⟨10.1002/ana.26009⟩ Moisse, M, Zwamborn, R A J, van Vugt, J, van der Spek, R, van Rheenen, W, Kenna, B, Van Eijk, K, Kenna, K, Corcia, P, Couratier, P, Vourc'h, P, Hardiman, O, McLaughin, R, Gotkine, M, Drory, V, Ticozzi, N, Silani, V, de Carvalho, M, Mora Pardina, J S, Povedano, M, Andersen, P M, Weber, M, Başak, N A, Chen, X, Eberle, M A, Al-Chalabi, A, Shaw, C, Shaw, P J, Morrison, K E, Landers, J E, Glass, J D, Robberecht, W, van Es, M, van den Berg, L, Veldink, J & Van Damme, P 2021, ' The Effect of SMN Gene Dosage on ALS Risk and Disease Severity ', Annals of neurology, vol. 89, no. 4, pp. 686-697 . https://doi.org/10.1002/ana.26009